Printer Friendly

BARR LABORATORIES RELEASES SECOND QUARTER FINANCIAL RESULTS

 POMONA, N.Y., Jan. 28 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL) has released financial results for the second quarter ended Dec. 31, 1992.
 Net sales in the second fiscal quarter of 1993 were $16,147,000 as compared to $30,633,000 for the comparable quarter last year, a 47.3 percent decrease. Net earnings for the quarter ended Dec. 31, 1992 were $95,000 or $.01 per share as compared to $728,000 or $.08 per share for the comparable quarter last year.
 Net sales for the six months ended Dec. 31, 1992 were $33,238,000 as compared to $59,602,000, a 44.2 percent decrease over the comparable period last year. Net earnings for the six months was $176,000 or $.02 per share as compared to net earnings of $1,775,000 or $.20 per share for the comparable period last year.
 The company's net earnings for the current quarter and year-to-date were achieved in spite of its continued voluntary suspension of certain products which has resulted in the decrease in net sales. In addition, the company incurred significant legal expenditures as a result of its ongoing dispute with the Food and Drug Administration (FDA). The company and the FDA have concluded their presentations of evidence in the New Jersey Federal District Court proceedings and are awaiting a decision. It should be noted that there has been no significant change in this litigation since the end of the first quarter.
 The company remains out of compliance with certain covenants of its senior and convertible notes. The company remains hopeful that a modification or waiver of these covenants will be obtained from its noteholders.
 Barr Laboratories is a prime manufacturer of a brand range of multi- source pharmaceutical products with manufacturing facilities located in both Northvale, N.J. and Pomona.
 BARR LABORATORIES, INC. AND SUBSIDIARIES
 Consolidated Statement of Earnings
 (Thousands of dollars except per share amounts, unaudited)
 Period ended Three months Six months
 Dec. 31 1992 1991 1992 1991
 Net sales $ 16,147 $30,633 $ 33,238 $ 59,602
 Costs and Expenses:
 Cost of sales 8,821 18,518 17,709 37,513
 Distribution 527 969 1,145 1,910
 Marketing and sales 1,201 1,945 2,579 3,795
 Research and development 1,232 1,817 2,655 3,948
 General and administrative 3,670 4,010 7,653 6,749
 Interest expense, net 537 619 1,190 1,247
 Other (income)/
 expense, net -- 1,600 13 1,622
 Earnings before
 income taxes 159 1,155 294 2,818
 Income tax provision 64 427 118 1,043
 Net earnings 95 728 176 1,775
 Net earnings per common
 share and common share
 equivalents $ 0.01 $ 0.08 $ 0.02 $ 0.20
 Weighted average number
 of common share and
 common share equivalents 8,632,062 8,672,576 8,625,367 8,662,813
 -0- 1/28/93
 /CONTACT: Harold Cohen, director of public relations of Barr Laboratories, Inc., 914-362-1100, ext. 2823/
 (BRL)


CO: Barr Laboratories, Inc. ST: New York IN: MTC SU: ERN

SH-OS -- NY024 -- 0141 01/28/93 10:17 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 28, 1993
Words:518
Previous Article:GOLDEX RAISES $2.05-MILLION FROM AGNICO-EAGLE TO PAY ORMICO FOR QUEBEC GOLD DEPOSIT
Next Article:BRISTOL-MYERS SQUIBB ANNOUNCES ELECTION OF SULLIVAN TO BOARD
Topics:


Related Articles
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR ANNOUNCES SECOND QUARTER SALES AND EARNINGS
BARR LABORATORIES RELEASES THIRD QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES THIRD QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR LABORATORIES' FIRST QUARTER NET SALES CLIMB 23%; NET EARNINGS UP 19%
Barr Laboratories Reports $0.15 EPS for Second Quarter 1997; Sales of $67 Million Represent 17% Increase
Barr Laboratories Reports Second Quarter EPS of $0.31 vs. $0.10 Last Year; Revenues Increase 37% to $92 Million; Net Earnings Climb 184% to $6 Million

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters